ALKEM — Alkem Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹572.69bn
- IN₹552.59bn
- IN₹115.99bn
- 97
- 16
- 98
- 86
C2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9,547 | 12,598 | 18,421 | 18,443 | 13,048 |
Depreciation | |||||
Non-Cash Items | 232 | 31.1 | -1,099 | -954 | 139 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3,914 | -9,306 | -7,418 | -9,419 | 534 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 7,797 | 5,851 | 12,649 | 11,110 | 16,825 |
Capital Expenditures | -5,292 | -3,631 | -1,949 | -3,389 | -2,329 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2,128 | -3,783 | -8,036 | -10,963 | 3,458 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,164 | -7,414 | -9,985 | -14,351 | 1,128 |
Financing Cash Flow Items | -546 | -651 | -536 | -401 | -905 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3,789 | 792 | -2,718 | 3,796 | -17,608 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 823 | -731 | -17.2 | 580 | 416 |